SCG在胃癌化疗前后的结果分析

Analysis of SCO Results before and after Chemotherapy of Gastric Carcinoma

本文用放射免疫分析法(RIA)和全自动生化分析仪对35例胃癌患者化疗前后血清甘氨胆酸(SCG),丙胺酸转氨酶(ALT),天门冬胺酸转氨酶(AST),碱性磷酸酶(ALP)和r—谷氨酰转肽酶(GGT)的变化进行了测定。结果提示化疗后SCG较正常对照和化疗前显著升高,且比各种酶指标升高更明显。故SCG可作为监测胃癌化疗对肝脏损害的一项灵敏指标。

With radio - immunity assay (RIA) and an automatic biochemical analyser, the authors analysed the SCG, ALT, AST, ALP and GGT changes before and after chemotherapy of 35 patients with gastric carcinoma. This study indicates significant rise of the SCG valuses post - chemotherapeutically determined of the patients as compared with those pre - chemotherapeutically determined and with the SCG values of the control group with normal liver function. Even more obvious rise of SCG values is shown compared with such indexes as ALT, AST, ALP and GGT. That is, SCG can be regarded as a sensitive index for monitoring damages from chemotherapy of gastric carcinoma to the liver.